- Q1 2024 Vericel Corp Earnings Call TranscriptMay 08, 2024$47.69 (-3.70%)Earnings
- Q4 2023 Vericel Corp Earnings Call TranscriptFeb 29, 2024$45.68 (-4.44%)Earnings
- Vericel Corp at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Q3 2023 Vericel Corp Earnings Call TranscriptNov 08, 2023$35.27 (-3.40%)Earnings
- Vericel Corp at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Q2 2023 Vericel Corp Earnings Call TranscriptAug 02, 2023$34.63 (-1.40%)Earnings
- Q1 2023 Vericel Corp Earnings Call TranscriptMay 10, 2023$34.19 (+4.11%)Earnings
- Q4 2022 Vericel Corp Earnings Call TranscriptFeb 23, 2023$30.6 (+7.29%)Earnings
- Vericel Corp at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Q3 2022 Vericel Corp Earnings Call TranscriptNov 09, 2022$17.65 (-23.43%)Earnings
- Q2 2022 Vericel Corp Earnings Call TranscriptAug 03, 2022$31.73 (-0.25%)Earnings
- Q1 2022 Vericel Corp Earnings Call TranscriptMay 04, 2022$31.05 (-0.99%)Earnings
- Q4 2021 Vericel Corp Earnings Call TranscriptFeb 24, 2022$38.88 (+20.82%)Earnings
- Vericel Corp at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2022
- Q3 2021 Vericel Corp Earnings Call TranscriptNov 09, 2021$42.15 (-2.20%)Earnings
- Vericel Corp at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 13, 2021
- Q2 2021 Vericel Corp Earnings Call TranscriptAug 04, 2021$49.18 (-4.91%)Earnings
- Vericel Corp at Ladenburg Thalmann Virtual Healthcare Conference TranscriptJul 13, 2021
- Vericel Corp at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2021
- Q1 2021 Vericel Corp Earnings Call TranscriptMay 05, 2021$56.59 (-4.33%)Earnings
- Vericel Corp Annual Shareholders Meeting TranscriptApr 28, 2021
- Q4 2020 Vericel Corp Earnings Call TranscriptFeb 24, 2021$49.45 (+4.39%)Earnings
- Vericel Corp at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- Vericel Corp at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 09, 2020
- Q3 2020 Vericel Corp Earnings Call TranscriptNov 05, 2020$21.73 (+2.50%)Earnings
- Vericel Corp Corporate Analyst Meeting TranscriptOct 16, 2020
- Vericel Corp at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 17, 2020
- Q2 2020 Vericel Corp Earnings Call TranscriptAug 05, 2020$15.92 (-5.35%)Earnings
- Vericel Corp at UBS Global Healthcare Conference (Virtual) TranscriptMay 20, 2020
- Q1 2020 Vericel Corp Earnings Call TranscriptMay 05, 2020$14.42 (+2.85%)Earnings
- Q4 2019 Vericel Corp Earnings Call TranscriptFeb 25, 2020$16.69 (-11.65%)Earnings
- Vericel Corp at Needham Growth Conference TranscriptJan 15, 2020
- Q3 2019 Vericel Corp Earnings Call TranscriptNov 05, 2019$18.34 (+12.86%)Earnings
- Vericel Corp at Morgan Stanley Healthcare Conference TranscriptSep 11, 2019
- Q2 2019 Vericel Corp Earnings Call TranscriptAug 06, 2019$18.6 (+5.14%)Earnings
- Vericel Corp at UBS Global Healthcare Conference TranscriptMay 22, 2019
- Q1 2019 Vericel Corp Earnings Call TranscriptMay 07, 2019$17.3 (-5.98%)Earnings
Vericel Corp at JPMorgan Healthcare Conference Transcript
Hi, everyone. I'd like to welcome you to the third day of the JPMorgan Healthcare Conference. I'm [Elizabeth Yugata] I'm a member of the Investment Banking Healthcare team and it is my pleasure to introduce the CEO of Vericel, Nick Colangelo.
Great. Well, thank you, Elizabeth. It's great to be here today. And before we begin, as always, I just want to remind everyone that our presentation contains forward looking statements so you should refer to our documents on file with the SEC for further information.
So Vericel is a leading provider of advanced therapies in the sports medicine and severe burn care market. We combine innovations in biology with medical technologies to create a highly differentiated portfolio of advanced cell therapies and specialty biologics that repair tissue and restore lives. Our lead product is MACI, which is an advanced cell therapy that uses a patient's own cells to restore damaged cartilage and restore function. MACI become
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)